ArticleEClinicalMedicine2023

Efficacy and safety of sintilimab plus albumin-bound-paclitaxel in recurrent or metastatic cervical cancer: a multicenter, open-label, single-arm, phase II trial.

Yin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.